Rapa Therapeutics

Texcell is a leading contract research organization specializing in viral testing, viral clearance, bioassays, in vivo testing, and GMP cell banking for R&D, GClP, GLP, and GMP projects. With a team of 140 employees across France, the United States, Germany, China, and Japan, Texcell serves customers worldwide and is set to expand with the inauguration of two new laboratories in 2023. Offering a range of services including cell banking, biosafety, viral clearance, and bioassays, Texcell is dedicated to supporting the growth and success of research and development projects. With a global presence and a focus on quality and innovation, Texcell is a trusted partner for organizations seeking expertise in viral testing and bioassays.Generated from the website

Medigen Inc. is a biomedical company based in Frederick, MD, dedicated to developing safe and effective vaccines targeting emerging diseases. Their mission is to protect human life by providing vaccines that offer long-lasting immunity against a variety of pathogens, including viruses such as Influenza, Chikungunya, and Dengue. Focusing on vaccine safety and the induction of natural immunity, Medigen's vaccines mimic natural viruses while ensuring safety for human use. The company's innovative technologies include Virus-Like Particles, RNA Vectors, and iDNA vaccines, aimed at combating both infectious diseases and cancers. Generated from the website

Orgenesis Inc, based in Germantown, MD, is a pioneering company dedicated to unlocking the full potential of cell and gene therapies (CGTs) in an affordable and accessible format. Their innovative POCare Platform offers a pathway to lower costs and standardized CGTs, aiming to bring advanced therapies to patients globally. With a focus on personalized CGTs, Orgenesis is committed to addressing the world's most challenging diseases. Through collaborations with biotech industry leaders, research institutes, and hospitals, they are revolutionizing drug development and scale-up, making advanced therapies more accessible to those in need.Generated from the website